The interaction of these IC molecules and their ligands with HLA-G/ILT2 axis may be relevant for the induction of a tolerogenic microenvironment, which in turn leads to the escape of tumor cells from the control of the immune system. The gene discussed is HLA-G; the disease is neoplasm.